A single-institution review of 157 patients presenting with benign and malignant tumors of the ampulla of Vater

LAUR Repository

Show simple item record

dc.contributor.author Azar, Riad
dc.contributor.author Hornick, John R.
dc.contributor.author Johnston, Fabian M.
dc.contributor.author Simon, Peter O.
dc.contributor.author Younkin, Morgan
dc.contributor.author Chamberlin, Michael
dc.contributor.author Mitchem, Jonathan B.
dc.date.accessioned 2016-06-22T09:02:09Z
dc.date.available 2016-06-22T09:02:09Z
dc.date.copyright 2011 en_US
dc.identifier.issn 0039-6060 en_US
dc.identifier.uri http://hdl.handle.net/10725/4125
dc.description.abstract Background Although benign ampullary tumors are removed endoscopically, due to their potential to progress to malignant disease, the favored treatment for adenocarcinoma is pancreaticoduodenectomy. We reviewed our institution's experience in order to identify which patients were at highest risk of disease progression following surgical resection, as well as evaluate whether localized T1 tumors are best treated by pancreaticoduodenectomy. Methods We retrospectively reviewed 157 patients who presented with an ampullary mass, from 2001 to 2010, and identified 51 with benign adenoma and 106 with adenocarcinoma. Results Patients with malignant tumors most often presented with larger tumors and jaundice, which alone was predictive of survival (OR = 67). Forty-five percent of patients with pathologically confirmed T1 tumors had positive lymph nodes and median survival was modest at 60 months. Lymph node involvement was predictive of recurrence and decreased survival. Conclusion Patients with malignant tumors often present with jaundice and larger tumors. These findings should warrant suspicion for cancer and expedited preoperative workup. Based on our finding that nearly half the patients with T1 tumors had positive lymph nodes, we recommend pancreaticoduodenectomy for any patient with biopsy proven adenocarcinoma who is a suitable candidate for surgery. With the exception of individuals with familial adenomatous polyposis (FAP), adenomas of the ampulla of Vater arise sporadically and rarely. These tumors necessitate removal because of their known progression to carcinoma and for relief of symptoms associated with blockage of the ampulla.1 Although they were traditionally treated surgically, advances in endoscopic technique has seen endoscopic papillectomy become an attractive alternative in the removal of benign ampullary adenomas.2 Ampullary adenocarcinomas are widely treated by pancreaticoduodenectomy (PD)3 because of their propensity to spread to lymph nodes and high incidence of recurrence. In some series preoperative endoscopic biopsy has a high rate of false negative results,4 prompting some researchers to recommend PD for all ampullary adenomas. Fit patients with tumors exhibiting high-grade dysplasia or adenocarcinoma are generally treated by PD with low recurrence rates.5 The perioperative mortality rate for PD has declined,6 and is widely accepted at academic care centers where the procedure is routinely performed. For ampullary adenocarcinoma postoperative survival rates are rising. Recent series report 5-year postoperative survival rates of 53–68%.7 Successful endoscopic removal of high-grade intraepithelial neoplasia, in situ tumors, and focal T1 cancers has been reported, but is not widely practiced.8, 9 and 10 For patients with slow-growing benign tumors, endoscopic resection is an attractive alternative with decreased cost and morbidity.11 and 12 Endoscopic papillectomy has a recurrence rate of 30% with 13.9% of endoscopically treated patients subsequently undergoing follow-up surgery. Success rates vary from 80% to 92% but have been high enough to prompt recommendation of endoscopic resection for benign ampullary tumors.13, 14 and 15 Endoscopic papillectomy's relatively low complication rate and the elimination of standard risks associated with surgery are advantageous. The high recurrence rate of the procedure is mitigated by follow-up endoscopic surveillance.2 Can the success of the endoscopic resection be extended to small localized T1 adenocarcinomas? Selection criteria have been suggested and small series and isolated cases in high risk individuals have been reported. Our institutional bias has been to surgically resect all patients with adenocarcinoma unless they are not acceptable surgical candidates. We anticipate that the debate on the roles of surgery and endoscopy in the treatment of small cancerous tumors will likely increase as experience with endoscopic resection increases. This study aims to evaluate the Washington University experience with tumors of the ampulla of Vater and present a strategy for optimal treatment of resectable tumors at the present time. en_US
dc.language.iso en en_US
dc.title A single-institution review of 157 patients presenting with benign and malignant tumors of the ampulla of Vater en_US
dc.type Article en_US
dc.description.version Published en_US
dc.title.subtitle management and outcomes en_US
dc.author.school SOM en_US
dc.author.idnumber 200902767 en_US
dc.author.department N/A en_US
dc.description.embargo N/A en_US
dc.relation.journal Surgery en_US
dc.journal.volume 150 en_US
dc.journal.issue 2 en_US
dc.article.pages 169-176 en_US
dc.identifier.doi http://dx.doi.org/10.1016/j.surg.2011.05.012 en_US
dc.identifier.ctation Hornick, J. R., Johnston, F. M., Simon, P. O., Younkin, M., Chamberlin, M., Mitchem, J. B., ... & Hawkins, W. G. (2011). A single-institution review of 157 patients presenting with benign and malignant tumors of the ampulla of Vater: management and outcomes. Surgery, 150(2), 169-176. en_US
dc.author.email riad.azar@lau.edu.lb en_US
dc.identifier.tou http://libraries.lau.edu.lb/research/laur/terms-of-use/articles.php en_US
dc.identifier.url http://www.sciencedirect.com/science/article/pii/S0039606011002121 en_US

Files in this item

Files Size Format View

There are no files associated with this item.

This item appears in the following Collection(s)

Show simple item record

Search LAUR

Advanced Search


My Account